ARID1A Mutations Are Associated with Increased Immune Activity in Gastrointestinal Cancer

Because traditional treatment strategies for advanced gastrointestinal (GI) cancers often have a limited therapeutic effect, immunotherapy could be a viable approach for the therapy of advanced GI cancers, considering the recent success of immunotherapy in treating various refractory malignancies, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Lin, Li, Mengyuan, Jiang, Zehang, Wang, Xiaosheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678467/
https://www.ncbi.nlm.nih.gov/pubmed/31277418
http://dx.doi.org/10.3390/cells8070678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678467/
https://www.ncbi.nlm.nih.gov/pubmed/31277418
http://dx.doi.org/10.3390/cells8070678

Ejemplares similares